Übernahmepoker: Evonik lehnt erhöhte Offerte von BASF ab
Das Unternehmen weist auch die nachgebesserte BASF-Offerte zurück. In Essen will man laut Insidern eigenständiger Akteur bei der Neuordnung der Chemieindustrie bleiben.
Düsseldorf - Special chemicals conglomerate Evonik has rejected the upgraded takeover offer from rival BASF, declaring it will not engage in discussions about a potential acquisition. On Friday, the company's board stated they remain committed to Evonik's independent path: "The board focuses on strategic alignment and development of Evonik as an independent entity."
Simultaneously, the board was open to an "informative and confidential exchange" with BASF. Evonik may keep the door open for further talks if the world's largest chemicals company comes back with a stronger offer. Sources suggest the latest bid was €24 per share, or about €11 billion. BASF's recent offer, along with assurances on jobs and locations, caused surprise at Evonik, insiders said.
Several key points that BASF is offering to win over Evonik are already in place with the company, including a ban on job cuts due to business conditions in Germany until 2032. The planned job cuts of 3,200 globally by the end of 2029, including roughly 2,150 in Germany, would be conducted through natural fluctuations, voluntary retirement schemes, and voluntary programs.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
